TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 5.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $307,000 | +51.2% | 21,600 | -12.6% | 0.02% | -33.3% |
| Q4 2017 | $203,000 | +48.2% | 24,700 | -16.3% | 0.03% | +57.1% |
| Q4 2016 | $137,000 | +57.5% | 29,500 | +106.3% | 0.02% | -82.6% |
| Q2 2016 | $87,000 | -47.3% | 14,300 | -26.3% | 0.12% | +70.4% |
| Q1 2016 | $165,000 | +34.1% | 19,400 | +87.5% | 0.07% | +65.1% |
| Q4 2015 | $123,000 | -77.7% | 10,349 | -68.8% | 0.04% | -68.1% |
| Q2 2015 | $551,000 | – | 33,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |